Thumbnail

The Rise of GLP-1 Therapies: Implications for Clinical Weight Loss Management

The Rise of GLP-1 Therapies: Implications for Clinical Weight Loss Management

Some medicinal formulations have been an unexpected discovery for weight loss and weight management. GLP-1 therapies, such as semaglutide and tirzepatide, are recent examples of this type. Healthcare experts recommend these drugs to patients with obesity or type 2 diabetes; in both conditions, excess weight gain and related health complications are common. They are mostly available in injectable forms; some places may also offer alternative forms. The shots need to go into the layer of fat under the skin to work. Because of this, you may have to take these injections in your belly, upper buttocks, back of the arms, or outer thighs. However, these medications are most effective for these clinical conditions when combined with proper dietary and lifestyle changes.

How do these weight loss medications work? Doctors prescribe the best GLP-1 medications for weight loss for their ability to act like a gut hormone that plays many important roles.

The role of GLP-1 drugs in weight loss management

You need an essential hormone like insulin for energy, and your food intake plays an important part in this. It helps your body use and store glucose for energy, keeping your blood sugar levels in check and reducing the risk of diabetes. GLP-1 can also affect glucose entering the bloodstream and slow stomach emptying, preventing blood sugar spikes after meals. Overall, it sends satiety signals to the brain, triggering a sense of fullness. GLP-1 medications manage all these aspects. As a result, type 2 diabetes patients experience slower digestion, which helps keep their blood sugar levels under control. On the other hand, their satiety effects make you eat less, offering better hunger and appetite regulation. All of these eventually lead to significant weight loss.

GLP-1 drugs for obesity in Type 2 Diabetes

The ability of these drugs to lower blood sugar levels is the main reason this treatment was approved for patients with type 2 diabetes. Earlier, doctors would recommend a specific type of oral medication to treat this condition. But their limited effectiveness in controlling blood sugar levels led doctors to prefer GLP-1 drugs along with lifestyle and dietary changes. When your blood sugar levels are controlled, you don't overeat due to continuous hunger pangs, which are often a source of weight gain.

GLP-1 drugs for obesity

A healthcare provider can advise one of the two options—semaglutide or tirzepatide—for weight loss. Obesity is a chronic health issue that becomes difficult to manage if there are coexisting conditions. However, these two medications have been demonstrated to be effective in clinical trials, leading to significant weight loss. To avoid relapses, clinicians encourage the use of these medications along with dietary changes, exercise, and other lifestyle modifications. When followed properly, you can avoid sharp increases in glucose levels, as the body processes sugar more slowly due to delayed digestion. The hormone glucagon may trigger the release of excess glucose into the bloodstream, but GLP-1 drugs reduce this effect. As a result, your chances of losing weight remain high.

Since researchers and clinicians noticed that these drugs do not just help regulate blood sugar levels but also reduce weight without aggressive diets or physical activity, semaglutide and tirzepatide have become powerful tools for clinical weight management.

Dr. Sergey Terushkin MD, FACS, FASMBS — Bariatric Surgeon

About Dr. Sergey Terushkin MD, FACS, FASMBS — Bariatric Surgeon

Dr. Sergey Terushkin is a highly respected surgeon specializing in general and bariatric surgery at Goal BMI General & Bariatric Surgery Clinic. Known for his patient-centered approach, Dr. Terushkin personally oversees every treatment plan at ThinERA, ensuring individualized care, thorough follow-up, and compassionate support at every stage of the journey.

Copyright © 2026 Featured. All rights reserved.
The Rise of GLP-1 Therapies: Implications for Clinical Weight Loss Management - Doctors Magazine